Mad Money Uncovered: PerkinElmer

After acquiring Amsterdam-based Patheon, TMO will continue its focus on collecting future companies into its back pocket.

Even though it has $1.5 billion of M&A capacity, PerkinElmer is unlikely to pursue a large bolt-on deal, according to Cantor Fitzgerald analyst Bryan Brokmeier.

Investors would also like to see the life science and tools company be more aggressive with its free cash flow.

Trade-Ideas LLC identified PerkinElmer (PKI) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Timing is everything, and investing short term may keep you from opportunities, Cramer says.